Open AccessEvaluation of the impact of renal impairment on the pharmacokinetics of glasdegib in otherwise healthy volunteers
Author(s) -
M. Naveed Shaik,
Robert R. LaBadie,
Brian Hee,
Geoffrey Chan
Publication year - 2021
Publication title -
cancer chemotherapy and pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.112
H-Index - 111
eISSN - 1432-0843
pISSN - 0344-5704
DOI - 10.1007/s00280-020-04207-9
Subject(s) - medicine , pharmacokinetics , renal function , confidence interval , adverse effect , urology
Glasdegib is being developed for indications in myeloid malignancies. The effect of renal impairment on the pharmacokinetics (PK) of a single, oral, 100-mg glasdegib dose under fasted conditions was assessed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom